SCHEMBL484547

SCHEMBL484547

O=C(NC1CCc2ccc(C(=O)N3CCC4(CCN(Cc5c(F)cccc5Cl)CC4)CC3)cc21)c1c(F)cccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 6/20 0.45
MAPK1 P28482 2/20 0.45
ACHE P22303 1/20 0.44
CYP3A4 P08684 4/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
USP2 O75604 1/20 0.41
ALDH1A1 P00352 4/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KDM4E B2RXH2 2/20 0.40
TSHR P16473 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CHRM2 P08172 1/20 0.39
CHRM3 P20309 1/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2817018 0.98 CYP2D6 (0.45) CYP2D6MAPK1ACHECYP3A4CYP1A2
SCHEMBL485201 0.93 CYP2D6 (0.48) CYP2D6MAPK1ACHECYP3A4CYP1A2
SCHEMBL485311 0.92 CYP2D6 (0.44) CYP2D6MAPK1ACHECYP3A4CYP1A2
SCHEMBL484806 0.92 ACHE (0.43) CYP2D6MAPK1ACHECYP3A4CYP1A2
SCHEMBL2818203 0.91 CYP2D6 (0.46) CYP2D6MAPK1CYP3A4CYP1A2CYP2C9
SCHEMBL2817754 0.90 CYP2D6 (0.47) CYP2D6MAPK1CYP3A4CYP1A2CYP2C9
SCHEMBL485299 0.90 CYP3A4 (0.57) CYP2D6MAPK1CYP3A4CYP1A2CYP2C9
SCHEMBL484502 0.90 ACHE (0.42) CYP2D6MAPK1ACHECYP3A4CYP1A2
SCHEMBL2817571 0.90 CYP2D6 (0.46) CYP2D6MAPK1CYP3A4CYP1A2CYP2C9
SCHEMBL485050 0.90 CYP2D6 (0.47) CYP2D6MAPK1CYP3A4CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885MAPK1 1001/4885ACHE 3999/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885MAPK1 1001/4885ACHE 3999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.